Trials / Conditions / Clostridium Difficile Diarrhea

Clostridium Difficile Diarrhea

10 registered clinical trials studyying Clostridium Difficile Diarrhea — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-ass NCT06839209	ABResearch S.r.l.	N/A
Withdrawn	Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonize NCT04246151	Hamilton Health Sciences Corporation	EARLY_Phase 1
Recruiting	Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) NCT04305769	University of Virginia	Phase 2
Completed	Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplan NCT03806803	University of Alberta	Phase 2
Terminated	A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea NCT03793686	Prolacta Bioscience	Phase 1
Unknown	Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS NCT03141775	University of Cologne	—
Terminated	Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Pat NCT02200328	Alison Schneider	Phase 4
Completed	A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea NCT00382304	Genzyme, a Sanofi Company	Phase 2
Terminated	Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenic NCT00772954	Sanofi	Phase 1
Completed	A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea NCT00034294	Genzyme, a Sanofi Company	Phase 2